Ishikawa, T., Imamura, K., Kondo, T., Koshiba, Y., Hara, S., Ichinose, H., . . . Inoue, H. (2016). Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders. Hum Mol Genet.
Chicago ZitierstilIshikawa, Taizo, et al. "Genetic and Pharmacological Correction of Aberrant Dopamine Synthesis Using Patient IPSCs With BH4 Metabolism Disorders." Hum Mol Genet 2016.
MLA ZitierstilIshikawa, Taizo, et al. "Genetic and Pharmacological Correction of Aberrant Dopamine Synthesis Using Patient IPSCs With BH4 Metabolism Disorders." Hum Mol Genet 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.